Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmaceutical Sciences, Inc. (PSI) was a contract development and manufacturing organization (CDMO) that provided specialized drug development services to the pharmaceutical and biotechnology industries. The company focused on formulation development, analytical testing, and clinical trial material manufacturing, with particular expertise in complex drug delivery systems and small molecule development. PSI supported clients from early-stage pre-formulation through to clinical supply manufacturing. In 2010, the company was acquired by PPD (Pharmaceutical Product Development) to strengthen PPD's Chemistry, Manufacturing, and Controls (CMC) and laboratory service capabilities. Following the acquisition, its operations were integrated into PPD's laboratory services division, which is now part of Thermo Fisher Scientific.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmaceutical Sciences.